Aurinia Pharmaceuticals, Inc. (AUPH)
15.61
+0.14
(+0.90%)
USD |
NASDAQ |
Apr 02, 16:00
15.70
+0.09
(+0.58%)
After-Hours: 20:00
Aurinia Pharmaceuticals Total Liabilities (Quarterly) : 189.26M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Xenon Pharmaceuticals, Inc. | 399.91M |
| Oncolytics Biotech, Inc. | 11.38M |
| Edesa Biotech, Inc. | 0.7562M |
| Lexaria Bioscience Corp. | 1.527M |
| ProMIS Neurosciences, Inc. | 10.44M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 770.59M |
| Shareholders Equity (Quarterly) | 581.33M |
| Debt to Equity Ratio | 0.1287 |
| Current Ratio | 5.249 |
| Net Debt Paydown Yield | 0.12% |